FDA approves first new type of pain medication in 25 years
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
News Medical on MSN1d
Pain coping skills training reduces pain and improves quality of life for dialysis patients
People undergoing hemodialysis treatment for kidney failure often experience chronic pain related to their condition, but it ...
Healio4d
Health equity guide aims to improve care for Black patients with serious illnesses
Black individuals in the U.S. with serious illnesses receive disproportionately poor pain management and health care ...
rheumatologyadvisor1d
An Introduction to Digital Therapy for Chronic Pain Management
Recent developments, however, suggest that strategies to treat pain are starting to match its complexity with a new ...
New Data Show Significant Pain Relief, Reduced Opioid Use, Decreased Patient Time and Cost Burdens with the ProsperaTM SCS System
BIOTRONIK Neuro will unveil new data from the BENEFIT-03 clinical study at the North American Neuromodulation Society (NANS) 2025 Annual Meeting. The findings highlight the transformative potential of ...
Why Women in Pain Are Still Begging Doctors to Listen
Women's pain is often misdiagnosed or ignored. But what's being done about it? We asked women and MDs to weigh in on.
The American Journal of Managed Care1d
Suzetrigine: First-in-Class Nonopioid Pain Therapy Is Approved by FDA
Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years and the first to be classified as ...
Everyday Health1d
FDA Approves First New Type of Pain Medication in More Than 20 Years
Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...
WROC Rochester on MSN1d
FDA approves opiate-alternative acute pain management drug, local experts share their thoughts
On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare ...
New type of non-opioid pain medication approved by FDA
( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first ...
Medscape1d
Acute Postoperative Pain Management in the Older Patient
Unfortunately, in up to 30–40% of patients that chronically consume opioids, opioid-induced hyperalgesia occurs. [59] This condition refers to a generalized and increasing pain sensitivity that ...